🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Dr. Yazan Alderazi at HCA Houston Healthcare on achieving first pass TICI 3 case using EMBOGUARD™, CEREGLIDE™ 71 and EMBOTRAP™ III! #hcahealthcare #EMBOGUARD #CEREGLIDE #EMBOTRAP US_CNV_ALLC_387942

At CERENOVUS, our employees' dedication drives innovation in #StrokeCare worldwide. Professionals like Kimberly Douglas bring passion and expertise, making a profound impact every day. We're proud to have them!

At Johnson and Johnson MedTech, we are committed to elevating stroke awareness and changing the trajectory of stroke care for physicians and patients around the globe.

Neurointerventional Future Leaders Program – an educational course designed to complement your fellowship journey through hands-on training and impactful curated content! Space is limited. Sign up now: bit.ly/3MQpspn

Thank you to Drs. Lucas Elijovich, Parita Bhuva, and J. Scott Pannell for leading our signature course on the TRUFILL™ n-BCA System. We appreciate your commitment to sharing clinical cases and leading discussions on strategy and complication avoidance.

Join us for another educational course through the Neurointerventional Future Leaders Program on October 24-25 in the sunny Palm Beach Gardens, FL! Level up your fellowship journey. Sign up now: bit.ly/3zrXNrW

We’re excited to share how Johnson & Johnson MedTech is contributing to the latest innovations in interventional and therapeutic neuroradiology at the 17th WFITN in New York City!🗽See you in October! Learn more about WFITN 2024: bit.ly/3Ngy2hL

The countdown to #WFITN2024 begins! We're headed to New York City on October 6-10, 2024 to showcase our premier product portfolio – including CEREPAK™, CEREGLIDE™ 71, and TRUFILL™ n-BCA. Stop by our booth to learn more about our innovations in #StrokeCare.

After multiple cases, Dr. Ezzeldin continues to succeed with EMBOTRAP™. “Never seen a clot that white on a stent retriever. Honestly, it's not only the clot burden…it’s the fibrin/cholesterol clot that stands out entrapped in the stent” (Dr. Ezzeldin). Details: 6.5x45 ET. Two

#WFITN2024 is right around the corner! We're excited to attend as Johnson & Johnson MedTech. Stop by our booth on October 6-10 to discover our commitment to changing the trajectory of stroke.

As we continue to innovate #StrokeCare, we are excited to share Dr. Edgar A. Samaniego’s experience with the CEREGLIDE™ 71 Intermediate Catheter with TruCourse™. Thank you for sharing your valuable insight using this device! Learn more about CEREGLIDE™ 71:

From education to our premier product portfolio, it's important to know the science, signs and symptoms behind a stroke. This #WorldStrokeDay, we're committed to ensuring you and your loved ones are prepared for the event of a stroke. Learn More: bit.ly/3YrtF8J

We're headed to sunny San Diego ☀️ November 20-22 for SVIN! Our team is excited to share how Johnson & Johnson MedTech is contributing to the field of interventional and therapeutic neuroradiology.

Join Dr. Fernando Vinuela as he shares his journey through interventional neuroradiology in our latest episode of “Neuro Innovation Talks” podcast. DeviceTalks Watch Now: bit.ly/4eA3NND Series: bit.ly/40Mj6zR

Join us at #SVIN24 on November 22nd at 10:30 to 10:40 for the latest MEMBRANE study results presented by Dr. Ansaar Rai. Dr. Rai is compensated by and presenting on behalf of J&J MedTech, and must present information in accordance with applicable regulatory requirements.

Join us at #SVIN24 on November 22nd at 10:30AM to 10:40AM for the latest MEMBRANE study results presented by Dr. Ansaar Rai. Dr. Rai is compensated by and presenting on behalf of J&J MedTech, and must present information in accordance with applicable regulatory requirements.

The latest study in the EXCELLENT Registry assesses the efficacy of the EMBOTRAP™ Revascularization Device in a real-world setting to advance stroke care and identifies the potential impact of clot composition among patients. See the full study here: bit.ly/3ZmA2vz

📣 NEW DATA: Dr. Raul G. Nigeria recently joined us at #SVIN2024 to present data from the EXCELLENT Registry – an all-comer, prospective, international, multi center, observational registry to assess the efficacy of the EMBOTRAP™ Revascularization Device in a real-world setting,

#NEWS: CEREGLIDE™ 92 Catheter System featuring INNERGLIDE 9™ is now commercially available in the United States! This .092’’ catheter system is the latest innovation to join the #CEREGLIDE family portfolio. #StrokeCare #JnJMedTech Learn more: bit.ly/3CZh4md